The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allogeneic Stem Cells Market Research Report 2025
Synopsis
Progesterone is a steroid hormone involved in the female menstrual cycle, pregnancy, and the embryonic development of humans and other species. Progesterone belongs to a class of hormones called progestogens. This steroid hormone is produced in the ovaries, the adrenal glands, and in the placenta during pregnancy.
The global Allogeneic Stem Cells market was valued at US$ 757.3 million in 2023 and is anticipated to reach US$ 1525.9 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
In the past, in the field of upstream production of steroid drugs, due to the late start of domestic biotechnology research, it was relatively backward compared to foreign manufacturers. However, after decades of development, China's production technology has been continuously improved, and its cost advantage is more obvious. Now, domestic steroid raw material manufacturers have gradually become the mainstream suppliers of steroid drug products, and foreign steroid drug giants have used steroid drugs upstream. Procurement of product starting materials and intermediates shifted to Asia-Pacific region, mainly China, and global steroid drug production center gradually moved to Asia-Pacific region.
The Progesterone is a high concentration industry. The annual production is about few hundred Tonnes. Currently, the global top three manufacturers are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical. Their revenue market share is about 52%. In short future, the competition pattern will not change.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cells.
Report Scope
The Allogeneic Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allogeneic Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva Generics
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Besins Healthcare
Virtus Pharmaceuticals
BionPharma
Segment by Type
Progesterone Oral
Progesterone Injection
Progesterone Suspended/Gel
Segment by Application
Hospital
Clinic
Pharmacies & Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Progesterone is a steroid hormone involved in the female menstrual cycle, pregnancy, and the embryonic development of humans and other species. Progesterone belongs to a class of hormones called progestogens. This steroid hormone is produced in the ovaries, the adrenal glands, and in the placenta during pregnancy.
The global Allogeneic Stem Cells market was valued at US$ 757.3 million in 2023 and is anticipated to reach US$ 1525.9 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
In the past, in the field of upstream production of steroid drugs, due to the late start of domestic biotechnology research, it was relatively backward compared to foreign manufacturers. However, after decades of development, China's production technology has been continuously improved, and its cost advantage is more obvious. Now, domestic steroid raw material manufacturers have gradually become the mainstream suppliers of steroid drug products, and foreign steroid drug giants have used steroid drugs upstream. Procurement of product starting materials and intermediates shifted to Asia-Pacific region, mainly China, and global steroid drug production center gradually moved to Asia-Pacific region.
The Progesterone is a high concentration industry. The annual production is about few hundred Tonnes. Currently, the global top three manufacturers are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical. Their revenue market share is about 52%. In short future, the competition pattern will not change.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cells.
Report Scope
The Allogeneic Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allogeneic Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva Generics
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Besins Healthcare
Virtus Pharmaceuticals
BionPharma
Segment by Type
Progesterone Oral
Progesterone Injection
Progesterone Suspended/Gel
Segment by Application
Hospital
Clinic
Pharmacies & Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Progesterone Oral
1.2.3 Progesterone Injection
1.2.4 Progesterone Suspended/Gel
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacies & Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cells Market Perspective (2019-2030)
2.2 Allogeneic Stem Cells Growth Trends by Region
2.2.1 Global Allogeneic Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allogeneic Stem Cells Historic Market Size by Region (2019-2024)
2.2.3 Allogeneic Stem Cells Forecasted Market Size by Region (2025-2030)
2.3 Allogeneic Stem Cells Market Dynamics
2.3.1 Allogeneic Stem Cells Industry Trends
2.3.2 Allogeneic Stem Cells Market Drivers
2.3.3 Allogeneic Stem Cells Market Challenges
2.3.4 Allogeneic Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cells Players by Revenue
3.1.1 Global Top Allogeneic Stem Cells Players by Revenue (2019-2024)
3.1.2 Global Allogeneic Stem Cells Revenue Market Share by Players (2019-2024)
3.2 Global Allogeneic Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allogeneic Stem Cells Revenue
3.4 Global Allogeneic Stem Cells Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cells Revenue in 2023
3.5 Allogeneic Stem Cells Key Players Head office and Area Served
3.6 Key Players Allogeneic Stem Cells Product Solution and Service
3.7 Date of Enter into Allogeneic Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cells Breakdown Data by Type
4.1 Global Allogeneic Stem Cells Historic Market Size by Type (2019-2024)
4.2 Global Allogeneic Stem Cells Forecasted Market Size by Type (2025-2030)
5 Allogeneic Stem Cells Breakdown Data by Application
5.1 Global Allogeneic Stem Cells Historic Market Size by Application (2019-2024)
5.2 Global Allogeneic Stem Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allogeneic Stem Cells Market Size (2019-2030)
6.2 North America Allogeneic Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allogeneic Stem Cells Market Size by Country (2019-2024)
6.4 North America Allogeneic Stem Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cells Market Size (2019-2030)
7.2 Europe Allogeneic Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allogeneic Stem Cells Market Size by Country (2019-2024)
7.4 Europe Allogeneic Stem Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cells Market Size (2019-2030)
8.2 Asia-Pacific Allogeneic Stem Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allogeneic Stem Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Allogeneic Stem Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cells Market Size (2019-2030)
9.2 Latin America Allogeneic Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allogeneic Stem Cells Market Size by Country (2019-2024)
9.4 Latin America Allogeneic Stem Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cells Market Size (2019-2030)
10.2 Middle East & Africa Allogeneic Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allogeneic Stem Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Allogeneic Stem Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Allogeneic Stem Cells Introduction
11.1.4 Merck Revenue in Allogeneic Stem Cells Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Teva Generics
11.2.1 Teva Generics Company Detail
11.2.2 Teva Generics Business Overview
11.2.3 Teva Generics Allogeneic Stem Cells Introduction
11.2.4 Teva Generics Revenue in Allogeneic Stem Cells Business (2019-2024)
11.2.5 Teva Generics Recent Development
11.3 Zhejiang Medicine
11.3.1 Zhejiang Medicine Company Detail
11.3.2 Zhejiang Medicine Business Overview
11.3.3 Zhejiang Medicine Allogeneic Stem Cells Introduction
11.3.4 Zhejiang Medicine Revenue in Allogeneic Stem Cells Business (2019-2024)
11.3.5 Zhejiang Medicine Recent Development
11.4 Zhejiang Aisheng Pharmaceutical
11.4.1 Zhejiang Aisheng Pharmaceutical Company Detail
11.4.2 Zhejiang Aisheng Pharmaceutical Business Overview
11.4.3 Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Introduction
11.4.4 Zhejiang Aisheng Pharmaceutical Revenue in Allogeneic Stem Cells Business (2019-2024)
11.4.5 Zhejiang Aisheng Pharmaceutical Recent Development
11.5 Besins Healthcare
11.5.1 Besins Healthcare Company Detail
11.5.2 Besins Healthcare Business Overview
11.5.3 Besins Healthcare Allogeneic Stem Cells Introduction
11.5.4 Besins Healthcare Revenue in Allogeneic Stem Cells Business (2019-2024)
11.5.5 Besins Healthcare Recent Development
11.6 Virtus Pharmaceuticals
11.6.1 Virtus Pharmaceuticals Company Detail
11.6.2 Virtus Pharmaceuticals Business Overview
11.6.3 Virtus Pharmaceuticals Allogeneic Stem Cells Introduction
11.6.4 Virtus Pharmaceuticals Revenue in Allogeneic Stem Cells Business (2019-2024)
11.6.5 Virtus Pharmaceuticals Recent Development
11.7 BionPharma
11.7.1 BionPharma Company Detail
11.7.2 BionPharma Business Overview
11.7.3 BionPharma Allogeneic Stem Cells Introduction
11.7.4 BionPharma Revenue in Allogeneic Stem Cells Business (2019-2024)
11.7.5 BionPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
